TABLE 1.

ZIC2 gene expression was associated with the prognosis of pan-cancer in PrognoScan.

Dataset	Cancer type	Endpoint	N	COX p-Value	HR [95% CI]
GSE13507	Bladder cancer	DSS	165	3.46E−05	2.16 [1.50–3.12]
GSE13507	Bladder cancer	OS	165	3.53E−05	1.82 [1.37–2.42]
GSE31210	Lung cancer	RFS	204	0.00039863	1.33 [1.13–1.55]
GSE1378	Breast cancer	RFS	60	0.00207109	1.54 [1.17–2.03]
GSE31210	Lung cancer	OS	204	0.00467843	1.35 [1.10–1.66]
GSE4922-GPL97	Breast cancer	DFS	249	0.0148796	1.24 [1.04–1.48]
GSE9893	Breast cancer	OS	155	0.0169037	1.89 [1.12–3.19]
GSE1379	Breast cancer	RFS	60	0.017022	1.31 [1.05–1.63]
GSE1456-GPL97	Breast cancer	DSS	159	0.0231347	1.46 [1.05–2.03]
GSE1456-GPL97	Breast cancer	RFS	159	0.0258117	1.37 [1.04–1.81]
GSE6532-GPL570	Breast cancer	RFS	87	0.0376658	1.38 [1.02–1.88]
GSE6532-GPL570	Breast cancer	DMFS	87	0.0376658	1.38 [1.02–1.88]